Design of a platform to rank chemotherapeutic drugs with a multidimensional approach

Use of ascitic fluid from patients to evaluate the mechanisms of action of PARP inhibitors

Evaluation of Histamine H3 and H4 Receptors as Prognostic Biomarkers in Triple-Negative Breast Cancer

The displacement of translesion DNA synthesis polymerases from the replisome sensitize tumor cells to genotoxins

CYTOTOXIC ACTION OF SHIGA TOXIN IN TRIPLE-NEGATIVE BREAST CANCER: POTENTIAL THERAPEUTIC USE AND INVOLVEMENT OF TDP-43

Anticancer activity of novel copper (II) compounds with an acylhydrazone ligands against 2D and 3D human breast cancer models.

Transcriptional factor STAT3 as a potential target for nanoparticle-delivered therapeutics, towards CD44+ breast cancer cells

MIR-28 IMPAIRS PROLIFERATION AND METASTATIC CHARACTERISTICS OF TRIPLE NEGATIVE BREAST CANCER CELLS